PubMed for id: 27190

Year	Number of Results
2000	2
2002	2
2003	1
2004	1
2005	3
2006	1
2009	1
2012	2
2013	3
2014	2
2015	2
2016	2
2017	3
2018	2
2019	1
2021	1
2022	1
2023	1
2024	0

1

Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes.

Ramirez-Carrozzi V, Ota N, Sambandam A, Wong K, Hackney J, Martinez-Martin N, Ouyang W, Pappu R. Ramirez-Carrozzi V, et al. J Immunol. 2019 Apr 1;202(7):1935-1941. doi: 10.4049/jimmunol.1800696. Epub 2019 Feb 15. J Immunol. 2019. PMID: 30770417

2

IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells.

Bie Q, Zhang B, Sun C, Ji X, Barnie PA, Qi C, Peng J, Zhang D, Zheng D, Su Z, Wang S, Xu H. Bie Q, et al. Oncotarget. 2017 Mar 21;8(12):18914-18923. doi: 10.18632/oncotarget.14835. Oncotarget. 2017. PMID: 28145881 Free PMC article.

3

Neutrophils produce interleukin-17B in rheumatoid synovial tissue.

Kouri VP, Olkkonen J, Ainola M, Li TF, Björkman L, Konttinen YT, Mandelin J. Kouri VP, et al. Rheumatology (Oxford). 2014 Jan;53(1):39-47. doi: 10.1093/rheumatology/ket309. Epub 2013 Sep 19. Rheumatology (Oxford). 2014. PMID: 24056520

4

[Eukaryotic expression and biological activity of recombinant human IL-17B protein].

Liu GQ, Li LB, Ju SG, Zhang WP, Qian YY, Zhu XF, Lu PR, Zhang XG. Liu GQ, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Mar;28(3):255-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012. PMID: 22394632 Chinese.

5

Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: a systematic review with META-analysis.

Husein-ElAhmed H, Steinhoff M. Husein-ElAhmed H, et al. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1735-1744. doi: 10.1111/jdv.18219. Epub 2022 May 24. J Eur Acad Dermatol Venereol. 2022. PMID: 35570406 Review.

6

A positive feedback loop of IL-17B-IL-17RB activates ERK/β-catenin to promote lung cancer metastasis.

Yang YF, Lee YC, Lo S, Chung YN, Hsieh YC, Chiu WC, Yuan SF. Yang YF, et al. Cancer Lett. 2018 May 28;422:44-55. doi: 10.1016/j.canlet.2018.02.037. Epub 2018 Feb 26. Cancer Lett. 2018. PMID: 29496538

7

The role of IL17B-IL17RB signaling pathway in breast cancer.

Alinejad V, Dolati S, Motallebnezhad M, Yousefi M. Alinejad V, et al. Biomed Pharmacother. 2017 Apr;88:795-803. doi: 10.1016/j.biopha.2017.01.120. Epub 2017 Feb 2. Biomed Pharmacother. 2017. PMID: 28160754 Review.

8

Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.

Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, Ji X, Wu Y, Guo Q, Wang S, Xu H. Bie Q, et al. Sci Rep. 2016 May 5;6:25447. doi: 10.1038/srep25447. Sci Rep. 2016. PMID: 27146881 Free PMC article.

9

Targeting interleukin-17 receptors.

Lee WH, Wu HH, Huang CK. Lee WH, et al. Oncotarget. 2015 Jul 30;6(21):18244-5. doi: 10.18632/oncotarget.4892. Oncotarget. 2015. PMID: 26285835 Free PMC article. No abstract available.

10

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW, Ma C, Lee WH. Wu HH, et al. J Exp Med. 2015 Mar 9;212(3):333-49. doi: 10.1084/jem.20141702. Epub 2015 Mar 2. J Exp Med. 2015. PMID: 25732306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year